Skip navigation

LONDON DRAWS IN LEADING LIFE SCIENCES INNOVATORS

17 May 2017

A leading US life sciences firm has doubled its presence in the UK by locating at Imperial College London’s White City Campus in west London. 

Health research and commercialisation services company, Mapi Life Sciences UK, is the latest business to join Imperial’s 23-acre research and innovation district in White City, reaffirming London’s position as a global centre for scientific and technological discovery.  The company has moved into the College’s Translation & Innovation Hub (I-HUB), which provides flexible office and lab space for businesses looking to turn cutting-edge research into new products and services.

Mapi is the premier health research and commercialisation company in the life sciences industry, with over 40 years experience of pioneering methodologies to support a more patient-centred approach to healthcare.  Mapi helps patients, healthcare practitioners and regulators to make treatment decisions based on personal treatment value.  Using its global expertise in developing and translating Clinical Outcome Assessments (COA) into practical applications, it generates and communicates real-world evidence on the value of treatments.

Located alongside Imperial research clusters in public health, molecular sciences and biomedical engineering, Mapi’s newest home in the UK, the I-HUB, forms part of the wider research and innovation community that Imperial is developing at the White City Campus.  By bringing together a network of world-class scientists, engineers and medics, as well as institutional and business partners, the campus will encourage new discussions and collaborations to help turn scientific and medical research into benefits for society.   

“Our new White City home will be a global leadership centre for Mapi, allowing our innovative management and operational leaders to tap into the knowledge and dynamism in the UK’s golden triangle of leading universities and entrepreneurs,” commented Mapi’s CEO, James Karis.  “The chance to be part of this research ecosystem and the scientific community that calls London home was a key factor in our decision to locate at the I-HUB.”

Dr Eulian Roberts, Chief Executive of Imperial College London ThinkSpace, which operates the I-HUB, said: “Mapi is a fantastic addition to the I-HUB.  It is committed to putting the patient at the heart of healthcare research and driving improvements in the way that medical treatment is delivered and experienced.

“Mapi joins a thriving enterprising environment at White City where the sharing of ideas and research will help us to reach new heights not just in medicine, but also in engineering, science and business.  Bringing together some of the world’s greatest minds in one place, we’ll be able to leverage their collective knowledge and tackle some of the biggest challenges facing us today.”

In addition to Mapi, the White City Campus is already home to a number of leading biotech and scientific research organisations.  Earlier this year it was announced that OGCI Climate Investments, a one billion dollar start up focused on advancing low-emission technology, would be the first tenant at Central Working White City – a new collaboration at the I-HUB between Imperial College London ThinkSpace and leading shared workspace provider, Central Working.  The I-HUB is also home to a business incubator for lab-based start-up and spin-out companies, such as Polymateria, a company that has developed a fully biodegradable plastic.